JNJ registry changes
Status changes, moved primary completion and completion dates, and results first posted on ClinicalTrials.gov, for trials linked to listed companies. Newest detection first.
Newest change detected Nov 19, 2026, 8:47 AM ET
| Detected | Trial | Change | Now | Before | Record updated |
|---|---|---|---|---|---|
| Nov 19, 2026, 8:47 AM ET | Completion date | Sep 2027 (sponsor estimate) | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Completion date | Mar 27, 2028 (sponsor estimate) | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Completion date | Nov 2027 (sponsor estimate) | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Completion date | Dec 31, 2027 (sponsor estimate) | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Completion date | Dec 31, 2027 (sponsor estimate) | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Completion date | Apr 2027 (sponsor estimate) | Locked | Locked |
- Detected Nov 19, 2026, 8:47 AM ETCompletion date
- Now
- Sep 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETCompletion dateNCT05197049A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's DiseaseJNJ
- Now
- Mar 27, 2028 (sponsor estimate)
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETCompletion dateNCT03767075A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets)JNJIQV
- Now
- Nov 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETCompletion dateNCT03431350A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate CancerJNJ
- Now
- Dec 31, 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETCompletion dateNCT02365597An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial CancerJNJ
- Now
- Dec 31, 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETCompletion dateNCT05601973Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous...JNJ
- Now
- Apr 2027 (sponsor estimate)
- Before
- Locked
The previous value and the sponsor's record update date are locked on 6 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerTracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.
What is on this list
Changes Signal8 recorded between two refreshes of a trial's ClinicalTrials.gov record: status, primary completion and completion dates, and results first posted. A change is shown when it was detected, which can be days after the sponsor updated the record. Nothing here describes what a trial showed.
New registrations, enrollment, eligibility and outcome-measure edits are not recorded. A status change is the registry's own word for where the trial stands, and "results posted" means results were posted to the registry, never what they show.
Free readers see the first 25 changes of any filter with the new value. The previous value, the sponsor's record update date and later pages are part of the plan. See the methodology.